Measuring Inactivation of Cryptosporidium Parvum by In Vitro Cell Culture

2003 ◽  
pp. 225-231 ◽  
Author(s):  
Paul A. Rochelle ◽  
Alexander A. Mofidi ◽  
Karl Linden ◽  
Ricardo De Leon
2002 ◽  
Vol 68 (8) ◽  
pp. 3809-3817 ◽  
Author(s):  
Paul A. Rochelle ◽  
Marilyn M. Marshall ◽  
Jan R. Mead ◽  
Anne M. Johnson ◽  
Dick G. Korich ◽  
...  

ABSTRACT In vitro cell cultures were compared to neonatal mice for measuring the infectivity of five genotype 2 isolates of Cryptosporidium parvum. Oocyst doses were enumerated by flow cytometry and delivered to animals and cell monolayers by using standardized procedures. Each dose of oocysts was inoculated into up to nine replicates of 9 to 12 mice or 6 to 10 cell culture wells. Infections were detected by hematoxylin and eosin staining in CD-1 mice, by reverse transcriptase PCR in HCT-8 and Caco-2 cells, and by immunofluorescence microscopy in Madin-Darby canine kidney (MDCK) cells. Infectivity was expressed as a logistic transformation of the proportion of animals or cell culture wells that developed infection at each dose. In most instances, the slopes of the dose-response curves were not significantly different when we compared the infectivity models for each isolate. The 50% infective doses for the different isolates varied depending on the method of calculation but were in the range from 16 to 347 oocysts for CD-1 mice and in the ranges from 27 to 106, 31 to 629, and 13 to 18 oocysts for HCT-8, Caco-2, and MDCK cells, respectively. The average standard deviations for the percentages of infectivity for all replicates of all isolates were 13.9, 11.5, 13.2, and 10.7% for CD-1 mice, HCT-8 cells, Caco-2 cells, and MDCK cells, respectively, demonstrating that the levels of variability were similar in all assays. There was a good correlation between the average infectivity for HCT-8 cells and the results for CD-1 mice across all isolates for untreated oocysts (r = 0.85, n = 25) and for oocysts exposed to ozone and UV light (r = 0.89, n = 29). This study demonstrated that in vitro cell culture was equivalent to the “gold standard,” mouse infectivity, for measuring the infectivity of C. parvum and should therefore be considered a practical and accurate alternative for assessing oocyst infectivity and inactivation. However, the high levels of variability displayed by all assays indicated that infectivity and disinfection experiments should be limited to discerning relatively large differences.


2004 ◽  
Vol 4 (2) ◽  
pp. 87-92
Author(s):  
P.A. Rochelle

Cryptosporidium parvum presents a significant problem for the water industry and public health officials because of its prevalence in sources of drinking water and its resistance to chlorine-based disinfectants; there is an urgent need for alternative, more effective disinfection strategies. Therefore, developing and evaluating methods for assessing the infectivity and inactivation of C. parvum oocysts are of paramount importance. Infectivity assays based on in-vitro cell culture have been developed as alternatives to human and animal-based assays to overcome ethical, cost, and practicality issues. Data obtained over a two-year period with an HCT-8 cell culture/RT-PCR infectivity assay generated an ID50 of 99 oocysts (95% CI: 84-117) and demonstrated that the cell culture assay was equivalent to the standard CD-1 mouse model for measuring infectivity of C. parvum oocysts. Aggregate data generated over two years using the HCT-8 cell culture/RT-PCR assay to measure UV disinfection of C. parvum demonstrated that 2.4 mJ/cm2 and 4.9 mJ/cm2 were necessary to achieve 1-log10 and 2-log10 inactivation, respectively. This work demonstrated that an HCT-8 cell culture-based infectivity coupled with RT-PCR for detecting C. parvum infections is a practical tool that can provide valuable information about the efficacy of disinfectants and the infectivity of oocysts in environmental waters.


1999 ◽  
Vol 65 (2) ◽  
pp. 841-845 ◽  
Author(s):  
Paul A. Rochelle ◽  
Ricardo De Leon ◽  
Anne Johnson ◽  
Mic H. Stewart ◽  
Roy L. Wolfe

ABSTRACT Two commercial immunomagnetic separation (IMS) kits forCryptosporidium were compared for recovery of oocysts from environmental samples. Oocyst recovery efficiencies with the Dynal and Crypto-Scan kits ranged from 62 to 100% and 34 to 74%, respectively, for seeded environmental water concentrates (turbidity of 210 to 11,480 nephelometric turbidity units). Recovery efficiencies were dependent on the mechanism of agitation during the magnetic capture procedure. An assay combining in vitro cell culture and reverse transcriptase PCR demonstrated that oocysts recovered by IMS retained their infectivity.


2013 ◽  
Vol 13 (2) ◽  
pp. 202-213 ◽  
Author(s):  
Mary Garvey ◽  
Jennifer Hayes ◽  
Eoghan Clifford ◽  
Dominik Kirf ◽  
Neil Rowan

This constitutes the first study to report on the use of a novel approach to determine inactivation in PUV-irradiated Cryptosporidium parvum oocysts suspended in water based on the measurement of cellular adenosine triphosphate (ATP) concentration. This study also compares the efficiency of a novel ATP assay to that of using the combined in vitro HCT-8 cell culture – quantitative polymerase chain reaction (qPCR) method for determining the inactivation in the waterborne pathogen C. parvum after exposure to pulsed UV (PUV) treatments. Findings were compared with using the combined cell culture-qPCR approach for determining oocyst viability in similarly treated samples. PUV effectively killed C. parvum with a 5.4 log10 loss in oocyst viability after exposure to a UV dose of 8.5 μJ/cm2 as determined by the in vitro cell culture – qPCR assay. The ATP assay was shown to be significantly less effective in measuring loss of oocyst viability in similarly PUV-irradiated samples for all combination of treatment regimes studied. Measurement of cellular ATP is not suitable as an indicator of the disinfection efficiency of PUV-irradiated C. parvum oocysts. The levels of ATP present post PUV-irradiated samples suggests that significant cellular activity remained in treated oocysts that are unable to invade human HCT-8 cells. However, further studies are merited to investigate factors that might aid repair post PUV treatments in this water-borne human parasite. Use of this ATP assay offers an interesting insight into loss of infectivity in PUV-treated C. parvum. This rapid assay does not appear suitable for investigating or optimizing treatment efficiency under varying operational settings as it detects PUV-treated oocysts at levels significantly higher compared with using the in vitro cell culture-qPCR infectivity assay. Overestimation of survivors by the ATP assay may suggest that a sub-population of C. parvum oocysts may exist in a viable but non-infectious state or may require a period of resuscitation to facilitate photo-repair (if possible) that may lead to regained ability to infective human hosts.


Pathogens ◽  
2020 ◽  
Vol 10 (1) ◽  
pp. 9
Author(s):  
Donghoon Kang ◽  
Natalia V. Kirienko

Pseudomonas aeruginosa is a multidrug-resistant, opportunistic pathogen that utilizes a wide-range of virulence factors to cause acute, life-threatening infections in immunocompromised patients, especially those in intensive care units. It also causes debilitating chronic infections that shorten lives and worsen the quality of life for cystic fibrosis patients. One of the key virulence factors in P. aeruginosa is the siderophore pyoverdine, which provides the pathogen with iron during infection, regulates the production of secreted toxins, and disrupts host iron and mitochondrial homeostasis. These roles have been characterized in model organisms such as Caenorhabditis elegans and mice. However, an intermediary system, using cell culture to investigate the activity of this siderophore has been absent. In this report, we describe such a system, using murine macrophages treated with pyoverdine. We demonstrate that pyoverdine-rich filtrates from P. aeruginosa exhibit substantial cytotoxicity, and that the inhibition of pyoverdine production (genetic or chemical) is sufficient to mitigate virulence. Furthermore, consistent with previous observations made in C. elegans, pyoverdine translocates into cells and disrupts host mitochondrial homeostasis. Most importantly, we observe a strong correlation between pyoverdine production and virulence in P. aeruginosa clinical isolates, confirming pyoverdine’s value as a promising target for therapeutic intervention. This in vitro cell culture model will allow rapid validation of pyoverdine antivirulents in a simple but physiologically relevant manner.


2013 ◽  
Vol 45 (4) ◽  
pp. 325 ◽  
Author(s):  
Anurupa Maitra ◽  
Shahnaz Patel ◽  
VijayR Bhate ◽  
VilliS Toddywalla ◽  
MaithiliA Athavale

1998 ◽  
Vol 42 (8) ◽  
pp. 1959-1965 ◽  
Author(s):  
Cynthia M. Theodos ◽  
Jeffrey K. Griffiths ◽  
Jennifer D’Onfro ◽  
Alexandra Fairfield ◽  
Saul Tzipori

ABSTRACT Nitazoxanide (NTZ), a drug currently being tested in human clinical trials for efficacy against chronic cryptosporidiosis, was assessed in cell culture and in two animal models. The inhibitory activity of NTZ was compared with that of paromomycin (PRM), a drug that is partially effective against Cryptosporidium parvum. A concentration of 10 μg of NTZ/ml (32 μM) consistently reduced parasite growth in cell culture by more than 90% with little evidence of drug-associated cytotoxicity, in contrast to an 80% reduction produced by PRM at 2,000 μg/ml (3.2 mM). In contrast to its efficacy in vitro, NTZ at either 100 or 200 mg/kg of body weight/day for 10 days was ineffective at reducing the parasite burden in C. parvum-infected, anti-gamma-interferon-conditioned SCID mice. Combined treatment with NTZ and PRM was no more effective than treatment with PRM alone. Finally, NTZ was partially effective at reducing the parasite burden in a gnotobiotic piglet diarrhea model when given orally for 11 days at 250 mg/kg/day but not at 125 mg/kg/day. However, the higher dose of NTZ induced a drug-related diarrhea in piglets that might have influenced its therapeutic efficacy. As we have previously reported, PRM was effective at markedly reducing the parasite burden in piglets at a dosage of 500 mg/kg/day. Our results indicate that of all of the models tested, the piglet diarrhea model most closely mimics the partial response to NTZ treatment reported to occur in patients with chronic cryptosporidiosis.


Sign in / Sign up

Export Citation Format

Share Document